XT-Thrive
Cell & Tissue Cryopreservation for Advanced Therapies
Pre-clinical/DevelopmentActive
Key Facts
Indication
Cell & Tissue Cryopreservation for Advanced Therapies
Phase
Pre-clinical/Development
Status
Active
Company
About X-Therma
X-Therma is developing a breakthrough biopreservation platform that emulates natural antifreeze mechanisms to enable longer, safer storage of biological materials. Its lead programs include XT-Thrive for cell therapy cryopreservation and XT-ViVo/TimeSeal for organ preservation, the latter having received FDA Breakthrough Device Designation in 2022. The company addresses significant unmet needs in organ transplantation, cell manufacturing, and IVF, where current standards using DMSO are toxic and limiting. By removing time and toxicity as barriers, X-Therma aims to unlock the full potential of regenerative medicines and organ transplants.
View full company profile